Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to evaluate dry mouth relief in subjects with self-reported feeling of dry mouth after using an experimental mouth rinse or a positive control compared to a water control.


Clinical Trial Description

This is a controlled, randomized, 3-treatment, parallel study for subjects with self-reported dry mouth symptoms as determined by an Oral Examination and subject responses to the Dry Mouth Inventory (DMI) questionnaire (see section 12) at the Acclimation visit. Qualified subjects will be randomly assigned to one of three treatments at the Baseline visit. Safety will be assessed by Oral Examinations at Baseline/Day1 and Day 8. Subjects will complete questionnaires before product use, immediately after product use (Day 1 only), and after 30 minutes, 1 hour, 2 hours, 4 hours and 6 hours of product use on Baseline/Day 1 and Day 8. The PPAQ II questionnaire will be completed on the morning of Day 8 (see study schedule for details). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04189081
Study type Interventional
Source Procter and Gamble
Contact
Status Completed
Phase N/A
Start date May 13, 2020
Completion date July 8, 2020

See also
  Status Clinical Trial Phase
Completed NCT04914208 - Effect of Wearing Face Masks on Salivary Parameters and Halitosis N/A
Completed NCT00601874 - Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting Conditions N/A
Completed NCT00601211 - Bioequivalency Study of 5 mg Piolocarpine Tablets Under Fed Conditions N/A
Completed NCT04152642 - A Pilot Study to Assess Dry Mouth Relief After Using an Experimental Mouth Rinse N/A
Completed NCT03215251 - Effectiveness of an Intervention Bundle on Thirst Intensity and Dry Mouth Among Patients in ICUs N/A
Completed NCT04632004 - Questionnaire Regarding the Effect of Wearing Face Masks on Oral Health N/A
Completed NCT05640362 - Efficacy of Natural Enzymes Mouthwash: a Randomised Controlled Trial N/A
Completed NCT04986501 - Clinical Evaluation of MucoPEG™ for Xerostomia N/A
Completed NCT05871580 - Effect to the Photobiomodulation in the Burning Mouth Syndrome N/A
Completed NCT06258603 - Oral Care of Intubated Intensive Care Patient N/A
Completed NCT01737307 - Effect of Fluoride Varnish and CPP-ACP on Oral and Salivary Symptoms During Chemotherapy Phase 2
Completed NCT01647737 - Green Tea Lozenges for the Management of Dry Mouth Phase 1/Phase 2
Active, not recruiting NCT03874572 - Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth Phase 1
Completed NCT03035825 - Efficacy of Oral Moisturizing Jelly on Oral Health and Nutrition in Post-radiotherapy Head and Neck Cancer Patients N/A
Recruiting NCT05964959 - A Mouth Education Program for Dry Mouth N/A
Withdrawn NCT02123147 - Examining the Immunological Process of Autoimmune Patients N/A
Completed NCT01885065 - Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients N/A
Completed NCT03281486 - "Hyaluronan" Formulation for Type 2 Diabetic Patients With Dry Mouth N/A
Not yet recruiting NCT05506137 - Xerostomia in Patients With a Life-limiting Condition or Frailty Phase 3
Completed NCT01690052 - Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva N/A